NIAID research aids discovery of genetic immune disorder
(NIH/National Institute of Allergy and Infectious Diseases) NIAID investigators and international colleagues have identified a genetic immune disorder characterized by increased susceptibility and poor immune control of Epstein-Barr virus (EBV) and, in some cases, an EBV-associated cancer called Hodgkin's lymphoma. The researchers studied two unrelated sets of siblings with similar immune problems and determined their symptoms were likely caused by a lack of CD70, a protein found on the surface of several types of immune cells.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Allergy | Allergy & Immunology | Cancer | Cancer & Oncology | Genetics | HIV AIDS | Hodgkin's Disease | Infectious Diseases | Lymphoma